Kobayashi K, Komada F, Otsuji A, Watanabe M, Fujii E, Kasai A, Yasuda M, Yokoyama N, Nakanishi M, Onishi H
Dept. of Internal Medicine, Matsusaka City Hospital.
Gan To Kagaku Ryoho. 1999 Feb;26(3):385-8.
We reported a 36-year-old woman with metastatic liposarcoma originating in the retroperitoneum, which responded well to adjuvant chemotherapy. The primary tumor was removed by surgery. Two months later, the patient developed metastasis to the brain, and to the lung four months later. Metastatic liposarcomas to the brain generally are extremely rare. The patient was treated with combination chemotherapy using cyclophosphamide, vincristine, adriamycin, and dacarbazine (CYVADIC). After she was examined, the former two drugs were alternated with vindesine and ifosfamide, and another regimen with cisplatin and etoposide was given after a three-week interval. As a result, both of the metastases totally disappeared. No recurrent lesion has been noted for two years. Although the role of chemotherapy for liposarcoma has not been well defined and little data support its use in an adjuvant setting, this combination chemotherapy seemed to be effective for advanced liposarcoma.
我们报告了一名36岁患有起源于腹膜后的转移性脂肪肉瘤的女性患者,该患者对辅助化疗反应良好。原发性肿瘤通过手术切除。两个月后,患者发生脑转移,四个月后发生肺转移。脑转移性脂肪肉瘤通常极为罕见。该患者接受了使用环磷酰胺、长春新碱、阿霉素和达卡巴嗪(CYVADIC)的联合化疗。在对她进行检查后,前两种药物被长春地辛和异环磷酰胺交替使用,三周后给予另一种含顺铂和依托泊苷的方案。结果,两处转移灶均完全消失。两年内未发现复发病变。尽管化疗在脂肪肉瘤中的作用尚未明确界定,且几乎没有数据支持其在辅助治疗中的应用,但这种联合化疗似乎对晚期脂肪肉瘤有效。